Picard Medical Inc PMI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $6.30
- Day Range
- $6.10–6.82
- 52-Week Range
- $2.65–208.00
- Bid/Ask
- $6.00 / $6.86
- Shares Outstanding
- 2.66M
- Market Cap
- $18.07M
- Volume/Avg
- 20,274 / 2M
Key Statistics
- Price/Earnings (Normalized)
- 0.87
- Price/Sales
- 2.10
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 75
Valuation
Metric | PMI |
|---|---|
Price/Earnings (Normalized) | 0.87 |
Price/Book Value | 11.65 |
Price/Sales | 2.10 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | PMI |
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.99 |
Interest Coverage | −169.47 |
Quick Ratio
PMI
Profitability
Metric | PMI |
|---|---|
Return on Assets (Normalized) | −167.05% |
Return on Equity (Normalized) | −819.58% |
Return on Invested Capital (Normalized) | −383.33% |
Return on Assets
PMI
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|#cWfj# | LOCK|qRPST | $180B | |||
| Medtronic PLC MDT | LOCK|LJ^HPl | LOCK|kbpn | $129B | |||
| Stryker Corp SYK | LOCK|qDSg!^G | LOCK|<<Q | $119B | |||
| Boston Scientific Corp BSX | LOCK|kpmLK>B | LOCK|m^qXq | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|!^>!Yhwh | LOCK|fyjTc | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|#?!lT@! | LOCK|>r | $37B | |||
| DexCom Inc DXCM | LOCK|dw>r>>V | LOCK|?TQWk | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|&&M | LOCK|Ts | $29B | |||
| Steris PLC STE | LOCK|G?h!#K | LOCK|mhgGY | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|<!l!DDD@ | LOCK|>bV | $19B |